Home / Scientific activities / Discussions / Department of clinical Pharmacy held a CE session entitled “Antiandrogen in COVID19: Plausible Faster Remission

Department of clinical Pharmacy held a CE session entitled “Antiandrogen in COVID19: Plausible Faster Remission

During this CE session lectured by Lect. Karrar Al-Gburi, A scientific data about the correlation between androgen hormone and the risk of SARS-COV2 infection has been discussed. At the end of the CE session, completed and ongoing clinical trials on using antiandrogen in treatment of COVID19 and their usefulness to provide rapid remission have been discussed

Check Also

Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies

Abstract: Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and progressive autoimmune disease …

Leave a Reply

Your email address will not be published.